publication date: Apr. 14, 2017


MD Anderson claims trademark infringement by Ohio state’s fundraiser

By Matthew Bin Han Ong

Every August, cyclists sign up for the Pelotonia ride that meanders through Ohio’s rolling hills.

More than just an enjoyable sporting event, Pelotonia, which benefits Ohio State, is one of the most successful fundraisers run for any cancer center. Over the past eight years, bikers who get sponsorship to ride up to 180 miles have brought in over $130 million for The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard Solove Research Institute.

Now, the race is threatened by a contest of another sort, one emanating from a competitor located some 1,200 miles away. In a recently filed lawsuit, MD Anderson Cancer Center is claiming that Pelotonia’s taglines “One Goal” and “One Goal: End Cancer” infringe the Houston cancer center’s trademark “One goal. Stop cancer.”

“We were surprised and caught off-guard by the lawsuit,” said Doug Ulman, president and CEO of Pelotonia, a limited liability corporation separate from Ohio State. “From my vantage point, what Pelotonia is focused on is very different than what MD Anderson is focused on. So, again, I think that leads to the frustration and, really, our shock and surprise that we experienced when they filed the suit.”

A conversation with Ulman appears here. Contacted by The Cancer Letter, MD Anderson officials   confirmed that the case is proceeding, declining to comment further.

Cancer centers, especially NCI-designated comprehensive cancer centers, have a tradition of collegiality. However, as the cancer centers’ business and academic relationships stretch across the country and even around the globe, their disputes can grow … Continue reading “ONE GOAL” VS. ANOTHER MD Anderson claims trademark infringement by Ohio state’s fundraiser

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.